Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine.

MLA

Haskelberg, Hila, et al. “Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine.” PLoS ONE, vol. 9, no. 4, Apr. 2014, pp. 1–8. EBSCOhost, https://doi.org/10.1371/journal.pone.0094858.

APA

Haskelberg, H., Pocock, N., Amin, J., Ebeling, P. R., Emery, S., & Carr, A. (2014). Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine. PLoS ONE, 9(4), 1–8. https://doi.org/10.1371/journal.pone.0094858

Chicago

Haskelberg, Hila, Nicholas Pocock, Janaki Amin, Peter Robert Ebeling, Sean Emery, and Andrew Carr. 2014. “Hip Structural Parameters over 96 Weeks in HIV-Infected Adults Switching Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine.” PLoS ONE 9 (4): 1–8. doi:10.1371/journal.pone.0094858.